当前位置：
X-MOL 学术
›
Nat. Rev. Immunol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Complement as a target in COVID-19?
Nature Reviews Immunology ( IF 100.3 ) Pub Date : 2020-04-23 , DOI: 10.1038/s41577-020-0320-7 Antonio M Risitano 1 , Dimitrios C Mastellos 2 , Markus Huber-Lang 3 , Despina Yancopoulou 4 , Cecilia Garlanda 5, 6 , Fabio Ciceri 7 , John D Lambris 8
Nature Reviews Immunology ( IF 100.3 ) Pub Date : 2020-04-23 , DOI: 10.1038/s41577-020-0320-7 Antonio M Risitano 1 , Dimitrios C Mastellos 2 , Markus Huber-Lang 3 , Despina Yancopoulou 4 , Cecilia Garlanda 5, 6 , Fabio Ciceri 7 , John D Lambris 8
Affiliation
There is an urgent need to develop effective therapies for COVID-19. Here, we urge immunologists and clinicians to consider the potential of targeting the complement system in these patients. This Comment article from Lambris and colleagues considers the therapeutic potential of targeting the complement system in patients with COVID-19.
中文翻译：
补充作为 COVID-19 的目标？
迫切需要为 COVID-19 开发有效的疗法。在这里，我们敦促免疫学家和临床医生考虑在这些患者中靶向补体系统的潜力。Lambris 及其同事的这篇评论文章考虑了针对 COVID-19 患者补体系统的治疗潜力。
更新日期：2020-04-24
中文翻译：
补充作为 COVID-19 的目标？
迫切需要为 COVID-19 开发有效的疗法。在这里，我们敦促免疫学家和临床医生考虑在这些患者中靶向补体系统的潜力。Lambris 及其同事的这篇评论文章考虑了针对 COVID-19 患者补体系统的治疗潜力。
京公网安备 11010802027423号